Pulmatrix Stock (NASDAQ: PULM) stock price, news, charts, stock research, profile.
Open | $2.070 |
Close | $2.040 |
Volume / Avg. | 6.762K / 15.398K |
Day Range | 2.000 - 2.070 |
52 Wk Range | 1.550 - 3.140 |
Market Cap | $7.341M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 0.08% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pulmatrix (NASDAQ: PULM) through any online brokerage.
Other companies in Pulmatrix’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Palisade Bio (NASDAQ:PALI).
The latest price target for Pulmatrix (NASDAQ: PULM) was reported by HC Wainwright & Co. on Tuesday, August 15, 2023. The analyst firm set a price target for 10.00 expecting PULM to rise to within 12 months (a possible 390.20% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Pulmatrix (NASDAQ: PULM) is $2.04 last updated April 26, 2024 at 3:29 PM EDT.
There are no upcoming dividends for Pulmatrix.
Pulmatrix’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Pulmatrix.
Pulmatrix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.